Obat key facts
as of Oct 2026- Developer of invoicing and payment software intended to serve small and medium enterprises in the construction industry.
- Obat is valued at approximately $24.9M as of Oct 2026 (last reported valuation).
- It has raised $19.1M; the latest was Debt - General in Jun 2025.
- Notable investors include Kima Ventures, ISAI, Crédit Mutuel Equity, Holnest, Evolem — 12 tracked in total.
- Status: Privately Held (backing).
Obat's last reported valuation, Jun 2025. Nothing priced has surfaced since.
- ·The complete investor list: 12 names
- ·Watch Obat: the Monday email on marks, rounds and moves
Obat funding rounds
No funding rounds for Obat are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Obat
12+Membership and data by Private Market View
Obat valuation
Obat's last reported valuation was $24.9 million in Jun 2025. No priced round, secondary trade or fund mark has surfaced since.
Obat investors
12 investors are on record for Obat, including Kima Ventures, ISAI, Crédit Mutuel Equity and Holnest.
About Obat
Developer of invoicing and payment software intended to serve small and medium enterprises in the construction industry. The company's platform specializes in estimation, project management, site monitoring, and building craftsmen invoices, enabling clients to focus on their operational business and maximize their value proposition.
- Sector
- Information Technology
- HQ
- Nantes, France
- Founded
- 2019
- Employees
- 80
- Website
- obat.fr/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.